Background
==========

Despite the impressive scientific progress in vaccination and chemotherapy, infectious diseases remain a serious health issue. Following the massive and inappropriate use of antibiotics, bacteria have developed various mechanism of resistance; consequently, infectious diseases remain one of the leading causes of morbidity worldwide \[[@B1]\]. Microbial infections constitute a major public health problem in developing countries \[[@B2]\] where the high cost of antibiotics makes them unaffordable to the majority of the population. Therefore, the discovery of new antimicrobial agents is still relevant nowadays. Among the bacterial resistance mechanisms, efflux of antibiotics plays an important role; In fact it is widely recognized that the expression of efflux pumps encoded by house-keeping genes in bacteria is largely responsible for the phenomenon of intrinsic antibiotic resistance \[[@B3]\]. Also, the shortcomings of the drugs available today and the scarcity of novel antibiotics propel the discovery of new chemotherapeutic agents from medicinal plants \[[@B4]\]. The medicinal properties of many phytochemicals have been demonstrated \[[@B5]\]. In addition, promising new concepts such as the efflux pump inhibitors \[[@B6],[@B7]\], and synergy between antibiotics and phytochemicals are now been explored.

The present work was therefore designed to investigate the antibacterial potential of four Cameroonian edible plants used traditionally in the treatment of bacterial infections, namely the fruits of *Piper nigrum* L (Piperaceae), the leaves of *Telfairia occidentalis* Hook. F. (Cucurbitaceae) and *Vernonia amygdalina* Del. (Asteraceae) and the fruits of *Syzygium aromaticum* \[L.\] Merr & Perry (Myrtaceae) against MDR bacteria expressing active efflux *via* the Resistance-Nodulation Cell Division (RND)-type pumps.

Methods
=======

Plant material and extraction
-----------------------------

The four edible plants used in this work were purchased from Dschang local market, West Region of Cameroon in June 2010. The collected plants material were the fruits of *Piper nigrum*, the fruits of *Syzygium aromaticum*, the leaves of *Telfairia occidentalis* and the leaves of *Vernonia amygdalina*. These plants were identified by M. Victor Nana of the National Herbarium (Yaounde-Cameroon) where all the voucher specimens were available under the reference numbers (see Table [1](#T1){ref-type="table"}). The air dried and powdered sample (1 kg) from each plant was extracted with methanol (MeOH) for 48 h at room temperature. The extracts were then filtered and concentrated under reduced pressure to give the crude extracts. All extracts were kept at 4°C until further investigations.

###### 

Plants used in the present study and evidence of their bioactivities

  **Plant (family); and voucher number**^**a**^            **Traditional uses**                                                                                                                                                                                                                                                                                             **Parts used**         **Bioactive or potentially bioactive components**                                                                     **Bioactivities of extracts and/or compounds**
  -------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------- --------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Piper nigrum* L. (Piperaceae); 25818/SFRcam             Cardiovascular diseases, intoxication, inflammation, bacterial, fungal and parasitic infections, respiratory diseases, asthma \[[@B8]\]                                                                                                                                                                          Seeds, bark, leaves    Piperine, pipene \[[@B9]\], piperamides, piperamine \[[@B10]\], pellitorine \[[@B11]\]                                Anti-apoptotic \[[@B12],[@B13]\], antibacterial \[[@B8],[@B14]\], antidepressant \[[@B15]\] antifungal \[[@B16]\], analgesic, anti-inflammatory \[[@B17]\], antidiarrhoeal \[[@B18]\], antimutagenic, antioxidative, increase plasma \[[@B19]\], antipyretic \[[@B17]\], immuno-modulatory, antispasmodic \[[@B20],[@B21]\], asthma, obesity, sinus antispermatogenic, antithyroid, antitumor Ciprofloxacin potentiator, transcription inhibitor, insecticidal, hepatoprotective, increase pancreatic enzymes, Cytochrome Inhibitor \[[@B8]\]
  *Syzygium aromaticum* (Myrtaceae) 28524/HNC              Aphrodisiac, used to treat male sexual disorders \[[@B22],[@B23]\], anti-inflammatory, bacterial infections \[[@B24]\], microbial infections \[[@B25],[@B26]\]                                                                                                                                                   fruits                 Eugenol (2-methoxy-4-(2-propenyl) phenol), glycosides, flavonoids, saponins and tannins \[[@B23]\], essential oils    Antipyretic, antispasmodic \[[@B27]\], anticarcinogenic \[[@B28]\], inhibition of 5-Lox enzyme activity in human polymorphonuclear leukocytes cells \[[@B29]\], antioxidant, protection against peroxynitrite-mediated tyrosine nitration and lipid peroxidation \[[@B29]\], antifungal activity of essential oil \[[@B26]\] and antimicrobial \[[@B25]\], antibacterial \[[@B30]\]
  *Telfairia occidentalis (*Curcubitaceae); 33423/HNC      Microbial infections, cholesterolemia, liver problems and impaired defense immune systems \[[@B31]\]                                                                                                                                                                                                             Leaves, seeds, roots   Phenols, alkaloids and tannins \[[@B32]\]                                                                             Antimicrobial, antioxidant and free radical-scavenger \[[@B32],[@B33]\], antiplasmodial, cure lactating properties, hypoglycemic and antidiabetic \[[@B31]\]
  *Vernonia amygdalina* Del. *(*Asteraceae ); 31149/SRFK   Microbial infections \[[@B34]\], hiccups, kidney and stomach problems, discomfort \[[@B35]\], stomach-ache and gastrointestinal infections, malarial fever , cough remedy \[[@B36]\], anti-malarial, purgative, anti-parasitic, eczema blood glucose levels control \[[@B37]\], treatment of eczema \[[@B37]\]   Leaves, roots          Flavonoids, saponins and alkaloids \[[@B36]\], vernodalin, vernomygdin, vernonioside B1 and vernoniol B1 \[[@B38]\]   Active anticancer \[[@B39]\], antimalarial and antiparasitic agents \[[@B40]\], Hypoglycaemic \[[@B41]\], antimicrobial, antibacterial \[[@B35],[@B40],[@B42]\], antihelminthic, anti-shitosomal, tumor inhibitor \[[@B38]\], hypolipidaemic and antioxidant properties \[[@B43]\]

^a^(HNC): Cameroon National Herbarium; (SRFC): *Société des réserves forestières du Cameroun*.

Preliminary phytochemical investigations
----------------------------------------

The major classes of secondary metabolites such as alkaloids, anthocyanins, anthraquinones, flavonoids, phenols, saponins, tannins, sterols and triterpenes were screened according to the common phytochemical methods described by Harbone \[[@B44]\].

Bacterial strains and culture media
-----------------------------------

The studied microorganisms included the reference (from the American Type Culture Collection) and clinical (Laboratory collection) strains of *Providencia stuartii, Pseudomonas aeruginosa, K. pneumoniae, Escherichia coli, Enterobacter aerogenes* and *Enterobacter cloacae* (See supporting information Additional file [1](#S1){ref-type="supplementary-material"}: Table S1 for their features). They were maintained in a Nutrient Broth at 4°C and activated on a fresh appropriate Mueller Hinton Agar plates 24 h prior to antimicrobial test. The Mueller Hinton Broth (MHB) was also used for all the antibacterial assays.

Chemicals for antimicrobial assays
----------------------------------

Tetracycline (TET), cefepime (FEP), cloxacillin (CLX), streptomycine (STR), ciprofloxacine (CIP), norfloxacine (NOR), chloramphenicol (CHL), cloxacillin (CLX), ampicillin (AMP), erythromycin (ERY), kanamycin (KAN) and streptomycin (STR) (Sigma-Aldrich, St Quentin Fallavier, France) were used as reference antibiotics. *p*-Iodonitrotetrazolium chloride (INT) and Phenylalanine Arginine *β*-naphthylamide (PAβN) were used as microbial growth indicator and efflux pumps inhibitor (EPI) respectively.

Bacterial susceptibility determination
--------------------------------------

The MICs were determined using the rapid INT colorimetric assay \[[@B45],[@B46]\]. Briefly, the test samples were first dissolved in DMSO/MHB. The solution obtained was then added to MHB, and serially diluted two fold (in a 96- wells microplate). One hundred microlitres (100 μL) of inoculum (1.5 × 10^6^ CFU/mL) prepared in MHB was then added. The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a shaker and incubated at 37°C for 18 h. The final concentration of DMSO was set at 2.5% (a concentration at which DMSO does not affect the microbial growth). Wells containing MHB, 100 μL of inoculum and DMSO at a final concentration of 2.5% served as negative control (this internal control was systematically added). Chloramphenicol was used as reference antibiotic. The MICs of samples were detected after 18 h incubation at 37°C, following addition of 40 μL of a 0.2 mg/mL INT solution and incubation at 37°C for 30 minutes. Viable reduce the yellow dye to pink. MIC was defined as the lowest sample concentration that exhibited complete inhibition of microbial growth and then prevented this change \[[@B47]\].

Samples were tested alone and the best three extracts (those from the seeds of *P. nigrum*, *T. occidentalis* and *V. amygdalina*) were also tested in the presence of PAβN at 30 mg/L final concentration. After a preliminary assay on one of the MDR bacteria, *P. aeruginosa* PA124 (See supporting information Additional file [1](#S1){ref-type="supplementary-material"}: Table S2), the two best extracts were those from *P. nigrum* and *T. occidentalis*. They were then selected and tested at MIC/2 and MIC/5 in association with antibiotics. Fractional inhibitory concentration (FIC) was calculated as the ratio of MIC~Antibiotic\ in\ combination~/MIC~Antibiotic\ alone~ and the results were discussed as follows: synergy (*≤* 0.5), indifferent (0.5 to 4), or antagonism (*\>* 4) \[[@B48],[@B49]\]. All assays were performed in triplicate.

Results
=======

Phytochemical composition and antibacterial activity of the extracts
--------------------------------------------------------------------

The results of the qualitative phytochemical analysis showed that each of the tested plant extract contains at least 3 classes of secondary metabolites (Table [2](#T2){ref-type="table"}). The antibacterial activities of the extracts alone and in some cases in combination with PAβN on a panel of 29 Gram-negative bacteria are depicted in Table [3](#T3){ref-type="table"}. It appears that extracts from *P. nigrum* and *V. amygdalina* inhibited the growth of all the twenty nine tested bacterial strains within a concentration range from 32 to 1024 μg/mL. A good spectrum of antibacterial activity was also recorded with the extract of *T. occidentalis,* its inhibitory effects being observed against 27/29 (93.1%) of the tested microorganisms. The lowest MIC value (32 μg/mL) was obtained with the extract of *P. nigrum* on *P. aeruginosa* PA01.

###### 

Extraction yields, aspects and phytochemical composition of the plant extracts

  **Scientific names**        **Part used**   **Yield**\* **(%)**   **Physical aspect**   **Secondary metabolites**                                     
  -------------------------- --------------- --------------------- --------------------- --------------------------- ---- ---- ---- ---- ---- ---- ---- ----
  *Piper nigrum*                 Fruits              13.18          Brown sticky paste               \+               \+   \+   \-   \-   \+   \+   \-   \-
  *Syzygium aromaticum*          Fruits              9.49            Dark brown paste                \+               \-   \-   \-   \-   \+   \-   \-   \-
  *Telfairia occidentalis*       Leaves              11.58          Brown sticky paste               \+               \+   \+   \-   \-   \+   \-   \+   \-
  *Vernonia amygdalina*          Leaves              7.16            Green dark paste                \+               \+   \+   \-   \+   \+   \-   \-   \+

(+): Present; (−): Absent; \*the yield was calculated as the ratio of the mass of the obtained methanol extract/mass of the plant powder.

###### 

Minimal Inhibitory Concentration (MIC) in μg/mL of methanol extracts from the studied plants and chloramphenicol

  **Bacteria strains**   **Plant extracts and MICs (μg/mL)**                                      
  ---------------------- ------------------------------------- ------ ------------- ------------- --------------
  *E. coli*                                                                                        
   ATCC8739              128                                   1024   512           512           4
   ATCC10536             256                                   \-     512           512           4
   W3110                 256                                   512    256           512           8
   MC4100                256                                   1024   512           512           16
   AG100A                128 (64)                              \-     512 (512)     512 (512)     \< 2 (\< 2)
   AG100Atet             256 (256)                             \-     512 (512)     1024 (1024)   64 (\< 2)
   AG102                 512 (128)                             \-     1024 (1024)   256 (256)     64
   AG100                 256 (32)                              \-     512 (512)     512 (32)      8 (\< 2)
  *E. aerogenes*                                                                                   
   ATCC13048             512                                   1024   512           512           8
   EA294                 512                                   \-     512           1024          16
   CM64                  512 (256)                             1024   256 (64)      256 (32)      256 (8)
   EA3                   512 (256)                             \-     1024 (1024)   512 (512)     256 (128)
   EA298                 256 (128)                             \-     512 (512)     256 (256)     64 (\< 2)
   EA27                  512 (256)                             \-     \-            1024 (1024)   ≥ 256 (\< 2)
   EA289                 512 (256)                             1024   512 (256)     256 (256)     ≥ 256 (64)
  *K. pneumoniae*                                                                                  
   ATCC11296             256                                   1024   1024          512           8
   KP55                  256 (64)                              \-     512 (512)     512 (512)     32 (4)
   KP63                  1024 (256)                            \-     256 (256)     1024 (1024)   64 (\< 2)
   K2                    512                                   \-     \-            1024          32
   K24                   512                                   \-     512           512           16
  *P. aeruginosa*                                                                                  
   PA01                  32                                    \-     512           512           16
   PA124                 256 (128)                             512    512 (512)     1024 (1024)   32 (\< 2)
  *P. stuartii*                                                                                    
   ATCC29916             128                                   \-     128           256           16
   NAE16                 512                                   1024   512           256           64
   PS2636                256                                   \-     512           512           32
   PS299645              1024 (1024)                           \-     1024          512           32
  *E. cloacae*                                                 \-                                  
   BM47                  128                                   \-     512           1024          ≥ 256
   ECCI69                128                                   \-     512           512           ≥ 256
   BM67                  128 (32)                              \-     512 (16)      1024 (1024)   128 (32)

(−) MIC \> 1024 μg/mL.

Role of efflux pumps in the susceptibility of Gram-negative bacteria to the tested plant extracts
-------------------------------------------------------------------------------------------------

Fourteen of the studied MDR bacteria were also tested for their susceptibility to the most active plant extracts (*P. nigrum*, *V. amygdalina* and *T. occidentalis*) in the presence PAβN at 30 μg/mL. When combined with extracts, PAβN improved the activity (decrease of MIC values) of *P. nigrum* on almost all of the tested MDR strains \[13/14 (92.9%)\]. The EPI also improved the activity of *T. occidentalis* against *E. aerogenes* CM64, EA 289 and *E. cloacae* BM67 as well as that of *V. amygdalina* against *E. coli* AG100 and *E. aerogenes* EA 289 (Table [3](#T3){ref-type="table"}).

Effect of the association of extracts with antibiotics
------------------------------------------------------

A preliminary study (See supporting information; Additional file [1](#S1){ref-type="supplementary-material"}: Table S2) was performed against *P. aeruginosa* PA124 using the three most active plant extracts. The results permitted the selection of the extracts from *P. nigrum* and *T. occidentalis* with the appropriate sub-inhibitory concentrations of MIC/2 and MIC/5 for further studies. Therefore, the extracts from *P. nigrum* and *T. occidentalis* were combined with eleven antibiotics \[TET, DOX, CIP, NOR, STR, KAN, CHL, ERY, FEP, CLX and AMP\] separately to evaluate their possible synergistic effects. As results, synergistic effects were observed with the two extracts and most of the tested antibiotics except ß-lactams (AMP, FEP and CLX) (Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}). At MIC/2 and MIC/5 of the extract from *T. occidentalis*, synergistic effects were observed with 7 of the 11 antibiotics (TET, DOX, CIP, NFX, KAN, CHL, ERY) against the tested MDR bacteria (Table [5](#T5){ref-type="table"}).

###### 

**MIC of different antibiotics after the association of the extract of*Piper nigrum*at MIC/2, MIC/5 against eleven MDR bacteria strains**

            **Bacterial strains, MIC (μg/mL ) of antibiotics in the absence and presence of the extract**                                                                                                                                                                     
  --------- ----------------------------------------------------------------------------------------------- --------------- --------------- --------------- --------------- --------------- ------------- ----------- -------------- --------------- --------------- -------- ----
  **TET**   0                                                                                               8               16              256             64              8               16            64          16             8               \> 256          4         
  MIC/2     4(2)^S^                                                                                         16(1)^I^        ≤ 2(≥ 128)^S^   16(4)^S^        ≤ 2(\> 4)^S^    4(4)^S^         16(4)^S^      16(1)^I^    8(1)^I^        \> 256          ≤2(\> 2)^S^     63.63    
  MIC/5     4(2)^S^                                                                                         16(1)^I^        ≤ 2(≥ 128)^S^   16(4)^S^        ≤ 2(\> 4)^S^    4(4)^S^         8(8)^S^       16(1)^I^    8(1)^I^        \> 256          ≤ 2(\> 2)^S^    63.63    
  **DOX**   0                                                                                               16              8               32              32              32              32            32          32             8               32              64       na
  MIC/2     8(2)^S^                                                                                         ≤ 2(\> 4)^S^    ≤ 2(\> 16)^S^   ≤ 2(\> 16)^S^   ≤ 2(\> 16)^S^   4(8)^S^         8(4)^S^       32(1)^I^    ≤ 2(\> 4)^S^   32(1)^I^        4(16)^S^        81.81    
  MIC/5     8(2)^S^                                                                                         ≤ 2(\> 4)^S^    ≤ 2(\> 16)^S^   ≤ 2(\> 16)^S^   4(8)^S^         ≤ 2(\> 16)^S^   8(4)^S^       16(1)^I^    ≤ 2(\> 4)^S^   32(1)^I^        ≤ 2(\> 32)^S^   81.81    
  **CIP**   0                                                                                               32              4               128             64              64              128           ≤ 2         8              128             64              128      na
  MIC/2     32(1)^I^                                                                                        ≤ 2(\>  2)^S^   16(8)^S^        4(16)^S^        8(8)^S^         64(2)^S^        ≤ 2           4(2)^S^     64(2)^S^       ≤ 2(\> 32)^S^   64(2)^S^        90       
  MIC/5     32(1)^I^                                                                                        ≤ 2(\> 2)^S^    64(2)^S^        16(4)^S^        4(16)^S^        64(2)^S^        ≤ 2           4(2)^S^     128(1)^I^      ≤ 2(\> 32)^S^   128(1)^I^       70       
  **NFX**   0                                                                                               128             128             64              128             ≤ 2             128           32          64             128             128             256      na
  MIC/2     64(2)^S^                                                                                        4(32)^S^        ≤2(\> 32)^S^    16(8)^S^        ≤ 2             32(4)^S^        8(4)^S^       16(4)^S^    128(1)^I^      16(8)^S^        128(2)^S^       90       
  MIC/5     128(1)^I^                                                                                       ≤ 2(\> 64)^S^   64(1)^I^        16(8)^S^        ≤ 2             32(4)^S^        16(2)^S^      16(4)^S^    128(1)^I^      16(8)^S^        128(2)^S^       80       
  **STR**   0                                                                                               256             ≤ 2             256             64              8               32            16          64             ≤ 2             4               64       na
  MIC/2     256(1)^I^                                                                                       ≤ 2             64(4)^S^        ≤ 2(\> 32)^S^   ≤ 2(\> 4)^S^    ≤ 2(\> 16)^S^   32(0.5)^I^    4(16)^S^    ≤ 2            ≤ 2(\> 2)^S^    ≤ 2(\> 32)^S^   77.78    
  MIC/5     256(1)^I^                                                                                       ≤ 2             64(4)^S^        ≤ 2(\> 32)^S^   ≤ 2(\> 4)^S^    4(8)^S^         16(1)^I^      4(16)^S^    ≤ 2            ≤ 2(\> 2)^S^    ≤ 2(\> 32)^S^   77.78    
  **KAN**   0                                                                                               ND              8               128             32              ≤2              16            16          32             ≤ 2             8               ≤ 2      na
  MIC/2     ND                                                                                              ≤ 2(\> 4)^S^    ≤ 2(\> 64)^S^   16(2)^S^        ≤2              ≤ 2(\> 8)^S^    4(4)^S^       4(8)^S^     ≤ 2            16(0.5)         ≤ 2             75       
  MIC/5     ND                                                                                              ≤ 2(\> 4)^S^    ≤ 2(\> 64)^S^   4(8)^S^         ≤2              ≤ 2(\> 8)^S^    4(4)^S^       4(8)^S^     ≤ 2            8(1)^I^         ≤ 2             75       
  **CHL**   0                                                                                               32              64              \> 256          64              256             32            \> 256      \> 256         64              16              128      na
  MIC/2     16(2)^S^                                                                                        4(16)^S^        16(\> 16)^S^    64(1)^I^        32(8)^S^        4(8)^S^         32(\> 8)^S^   \> 256      32(2)^S^       8(2)^S^         8(16)^S^        81.81    
  MIC/5     32(1)^I^                                                                                        16(4)^S^        16(\> 16)^S^    64(1)^I^        128(2)^S^       4(8)^S^         64(\> 4)^S^   \> 256      32(2)^S^       16              128(1)^I^       54.54    
  **ERY**   0                                                                                               128             32              256             128             \> 256          256           64          256            256             256             256      na
  MIC/2     128(1) ^I^                                                                                      8(4)^S^         64(4)^S^        256(0.5)^I^     32(\> 8)^S^     64(4)^S^        32(2)^S^      256(1)^I^   64(4)^S^       16(16)^S^       64(4)^S^        72.72    
  MIC/5     128(1)^I^                                                                                       16(2)^S^        32(4)^S^        128(1)^I^       8(\> 32)^S^     256(1)^I^       8(8)^S^       256(1)^I^   128(2)^S^      16(16)^S^       64(4)^S^        63.63    
  **AMP**   0                                                                                               128             128             \> 256          \> 256          \> 256          \> 256        \> 256      \>256          \> 256          \> 256          \> 256   na
  MIC/2     128(1)^I^                                                                                       128(1)^I^       \> 256          \> 256          \> 256          \> 256          \> 256        \> 256      \> 256         \> 256          \> 256          na       
  MIC/5     128(1)^I^                                                                                       128(1)^I^       \> 256          \> 256          \> 256          \> 256          \> 256        \> 256      \> 256         \> 256          \> 256          na       
  **FEP**   0                                                                                               \> 256          \> 256          \> 256          \> 256          \> 256          \> 256        \> 256      \> 256         \> 256          \> 256          \> 256   na
  MIC/2     \> 256                                                                                          \> 256          \> 256          \> 256          \> 256          \> 256          \> 256        \> 256      \> 256         \> 256          \> 256          na       
  MIC/5     \> 256                                                                                          \> 256          \> 256          \> 256          \> 256          \> 256          \> 256        \>256       \> 256         \> 256          \> 256          na       
  **CLX**   0                                                                                               \> 256          \> 256          \> 256          \> 256          \> 256          \> 256        \> 256      \> 256         \> 256          \> 256          \> 256   na
  MIC/2     \> 256                                                                                          16(\> 16)^S^    \> 256          \> 256          \> 256          \> 256          \> 256        \> 256      \> 256         \> 256          \> 256          1.1      
  MIC/5     \> 256                                                                                          32(\> 8)^S^     \> 256          \> 256          64(\> 4)^S^     \> 256          \> 256        \> 256      \> 256         \> 256          \> 256          18.2     

^a^Antibotics \[*TET* : tetracycline, *DOX*: doxycyclin, *CIP* : ciprofloxacin, *NOR* : norfloxacin, *STR* : streptomycin, *KAN* : kanamycin, *CHL*: chloramphenicol, *ERY* : erythromycin, *AMP* : ampicillin, *FEP*: cefepime, *CLX* : cloxacillin\]. ^b^Bacterial strains: *Escherichia coli* \[AG100, AG100A, AG100Atet\], *Pseudomonas aeruginosa* \[PA124\], *Enterobacter aerogenes* \[CM64, EA3, EA27, EA289\], *Enterobacter cloacae* \[BM67\], *Klebsiella pneumoniae* \[KP55\], *Providencia stuartii* \[NAE16\]. ^c^PBSS: percentage of bacteria strain on which synergism has been observed; (): fold increase in MIC values of the antibiotics after association with plants extract; S: Synergy, I: Indifference; na: not applicable.

###### 

**MIC of different antibiotics after the association of the extract of*Telfairia occidentalis*at MIC/2, MIC/5 against eleven MDR bacteria**

   **Antibiotics**^**a**^   **Bacterial strains**^**b**^**, MIC (μg/mL ) of antibiotics in the absence and presence of the extract**                 **PBSS**^**c**^**(%)**                                                                                                                                          
  ------------------------ ---------------------------------------------------------------------------------------------------------- -------------- ------------------------ --------------- ---------------- --------------- -------------- --------------- -------------- --------------- -------------- -------- ------
            TET                                                                0                                                      8              16                       256             64               8               16             64              16             8               \> 256         4           
           MIC/2                                                            4(2)^S^                                                   8(2)^S^        256(1)^I^                32(2)^S^        ≤ 2(\> 4)^S^     ≤ 2(\> 8)^S^    64(1)^I^       8(2)^S^         4(2)^S^        256(\> 1)^s^    ≤ 2(\> 2)^S^   81.8     
           MIC/5                                                            4(2)^S^                                                   8(2)^S^        256(1)^I^                32(2)^S^        ≤ 2(\> 4)^S^     ≤ 2(\> 8)^S^    64(1)^I^       8(2)^S^         4(2)^S^        256(\> 1)^s^    4(1)^I^        72.7     
            DOX                                                                0                                                      16             8                        32              32               32              32             32              32             8               32             64         na
           MIC/2                                                            2(8)^S^                                                   ≤ 2(\> 4)^S^   16(2)^S^                 4(8)^S^         4(8)^S^          ≤ 2(\> 16)^S^   4(8)^S^        16(2)^S^        4(2)^S^        ≤ 2(\> 16)^S^   32(2)^S^       100      
           MIC/5                                                            8(2)^S^                                                   ≤ 2(\> 4)^S^   32(1)^I^                 8(4)^S^         ≤ 2(\> 16)^S^    ≤ 2(\> 16)^S^   8(4)^S^        16(2)^S^        ≤ 2(\> 4)^S^   64(\< 0.5)      64(1)^I^       72.7     
            CIP                                                                0                                                      32             4                        128             64               64              128            ≤ 2             8              128             64             128        na
           MIC/2                                                            32(1)^I^                                                  ≤ 2(\> 2)^S^   64(2)^S^                 ≤ 2(\> 32)^S^   16(4)^S^         ≤ 2(\> 64)^S^   ≤ 2            ≤ 2(\> 4)^S^    128(1)^I^      ≤ 2(\> 32)^S^   128(1)^I^      70       
           MIC/5                                                            32(1)^I^                                                  ≤ 2(\> 2)^S^   64(2)^S^                 ≤ 2(\> 32)^S^   16(4)^S^         ≤ 2(\> 64)^S^   ≤ 2            ≤ 2(\> 4)^S^    128(1)^I^      ≤ 2(\> 32)^S^   128(1)^I^      70       
            NFX                                                                0                                                      128            128                      64              128              ≤ 2             128            32              64             128             128            256        na
           MIC/2                                                            64(2)^s^                                                  4(32)^S^       32(2)^S^                 4(32)^S^        ≤ 2              4(32)^S^        4(8)^S^        32(2)^S^        128(1)^I^      ≤ 2(\> 64)^S^   128(2)^S^      90       
           MIC/5                                                            32(4)^s^                                                  4(32)^S^       32(2)^S^                 4(32)^S^        ≤ 2              4(32)^S^        4(8)^S^        16(4)^S^        128(1)^I^      8(16)^S^        256(1)^I^      80       
            STR                                                                0                                                      256            ≤ 2                      256             64               8               32             16              64             ≤ 2             4              64         na
           MIC/2                                                           256(1)^I^                                                  ≤ 2            256(1)^I^                16(4)^S^        ≤ 2(\> 4)^S^     ≤ 2(\> 16)^S^   16(1)^I^       ≤ 2(\> 32)^S^   ≤ 2            ≤ 2(\> 2)^S^    16(4)^S^       66.7     
           MIC/5                                                           256(1)^I^                                                  ≤ 2            256(1)^I^                8(8)^S^         ≤ 2(\> 4)^S^     ≤ 2(\> 16)^S^   16(1)^I^       ≤ 2(\> 32)^S^   ≤ 2            ≤ 2(\> 2)^S^    16(4)^S^       66.7     
            KAN                                                                0                                                      ND             8                        128             32               ≤ 2             16             16              32             ≤ 2             8              ≤ 2        na
           MIC/2                                                               ND                                                     4(2)^S^        128(1)^I^                8(4)^S^         ≤ 2              ≤ 2(\> 8)^S^    ≤ 2(\> 8)^S^   ≤ 2(\> 16)^S^   ≤ 2            8(1)^I^         ≤ 2            71.4     
           MIC/5                                                               ND                                                     4(2)^S^        128 (1)^I^               ≤ 2(\> 16)^S^   ≤ 2              ≤ 2(\> 8)^S^    ≤ 2(\> 8)^S^   ≤ 2(\> 16)^S^   ≤ 2            8(1)^I^         ≤ 2            71.4     
            CHL                                                                0                                                      32             64                       \> 256          64               256             32             \> 256          64             16              128            128        na
           MIC/2                                                            16(2)^s^                                                  32(2)^S^       \> 256                   64(1)^I^        ≤ 2(\> 128)^S^   4(8)^S^         256(\> 1)^s^   16(4)^S^        ≤ 2(\> 8)^S^   16(8)^S^        16(8)^S^       90       
           MIC/5                                                            32(1)^I^                                                  32(2)^S^       \> 256                   64(1)^I^        ≤ 2(\> 128)^S^   8(4)^S^         256(\> 1)^s^   32(2)^S^        16(1)^I^       64(2)^S^        64(2)^S^       70       
            ERY                                                                0                                                      128            32                       256             128              \> 256          256            64              256            256             256            256        na
           MIC/2                                                            64(2)^s^                                                  16(2)^S^       \> 256                   32(4)^S^        ≤ 2              4(64)^S^        32(2)^S^       64(4)^S^        32(8)^S^       8(32)^S^        128(2)^S^      72.7     
           MIC/5                                                            64(2)^s^                                                  32(1)^I^       \> 256                   32(4)^S^        64(\> 4)^S^      4(64)^s^        64(1)^I^       256(1)^I^       32(8)^S^       16(16)^S^       128(2)^S^      45.5     
            AMP                                                                0                                                      128            128                      \> 256          \> 256           \> 256          \> 256         \> 256          \> 256         \> 256          \> 256         \> 256     na
           MIC/2                                                          256(0.5) ^I^                                                128(1)^I^      \> 256                   \> 256          \> 256           256(\> 1)^s^    \> 256         \> 256          \> 256         \> 256          \> 256         na       
           MIC/5                                                          256(0.5) ^I^                                                128(1)^I^      \> 256                   \> 256          \> 256           \> 256          \> 256         \> 256          \> 256         \> 256          \> 256         na       
            FEP                                                                0                                                      ND             \> 256                   \> 256          \> 256           \> 256          \> 256         \> 256          \> 256         256             \> 256         \> 256     na
           MIC/2                                                               ND                                                     \> 256         \> 256                   \> 256          \> 256           \> 256          \> 256         \> 256          \> 256(\< 1)   8(\> 32)^S^     \> 256         1.1      
           MIC/5                                                               ND                                                     \> 256         \> 256                   \> 256          \> 256           \> 256          \> 256         \> 256          \> 256(\< 1)   \> 256          \> 256         na       
            CLX                                                                0                                                      \> 256         256                      \> 256          \> 256           \> 256          \> 256         \> 256          \> 256         \> 256          \> 256         \> 256     na
           MIC/2                                                             \> 256                                                   64(\> 4)^S^    \> 256                   \> 256          256(≥2) ^S^      64(\> 4)^S^     \> 256         \> 256          \> 256         \> 256          \> 256         27.3     
                                                                             MIC/5                                                    \> 256         64(\> 4)^S^              \> 256          \> 256           256(≥2) ^S^     128(\> 2)^S^   \> 256          \> 256         \> 256          \> 256         \> 256    27.3

^a^Antibotics \[*TET* : tetracycline, *DOX*: doxycyclin, *CIP*: ciprofloxacin, *NOR* : norfloxacin, *STR* : streptomycin, *KAN* : kanamycin, *CHL*: chloramphenicol, *ERY* : erythromycin, *AMP* : ampicillin, *FEP*: cefepime, *CLX*: cloxacillin\]. ^b^Bacterial strains: *Escherichia coli* \[AG100, AG100A, AG100Atet\], *Pseudomonas aeruginosa* \[PA124\], *Enterobacter aerogenes* \[CM64, EA3, EA27, EA289\], *Enterobacter cloacae* \[BM67\], *Klebsiella pneumoniae* \[KP55\], *Providencia stuartii* \[NAE16\]. ^c^PBSS: percentage of bacteria strain on which synergism has been observed; (): fold increase in MIC values of the antibiotics after association with plants extract; S: Synergy, I: Indifference; na: not applicable tract; S: Synergy, I: Indifference; na: not applicable.

Discussion
==========

Antibacterial activities and chemical composition of the tested extracts
------------------------------------------------------------------------

Many secondary metabolites belonging to alkaloids, anthocyanins, anthraquinons, flavonoids, phenols, saponins, sterols, tannins and triterpenes were detected in the tested plant extracts. Several compounds from the investigated classes of phytochemicals were reported for their antibacterial activities \[[@B50],[@B51]\], and their presence in the tested extracts could explain their antibacterial effects. The differences in bacterial susceptibility to the extracts may be either due to the differences in cell wall composition and/or genetic content of their plasmids \[[@B52]\] or to the differences in the composition and the mechanism of action of the bioactive compounds \[[@B53]\]. As shown in Table [3](#T3){ref-type="table"}, the three most active plants (*P. nigrum, T. occidentalis* and *V. amygdalina*) possess more classes of phytochemicals than the extract from *S. aromaticum*. Each of the three most active plant extracts contains at least four classes of secondary metabolites namely alkaloids, phenols, flavonoids and tannins. However, it should be noted that the activity does not depend on the number of classes of detected bioactive compounds, but mostly on their concentration. The inhibitory activity of *P. nigrum* was previously reported against some bacteria such as *Staphylococcus aureus*, *Bacillus cereus*, *Streptococcus faecalis*, *Pseudomonas aeruginosa*, *Salmonella typhi* and *Escherichia coli*\[[@B54]\], and the data reported in this study confirms the anti-infective potential of this plant. It has also been demonstrated that the acetone-ethanol extract of the leaves from *V. amygdalina* was weakly active against *K*. *pneumoniae, E. coli, S. aureus*, *B. cereus, S. dysentriae* and *S. typhimurium*\[[@B35]\] with MIC values ranged from 7.5 mg/mL to 25 mg/mL \[[@B42]\]. These activities are in accordance with the results obtained in the present work, but we observed higher antibacterial activity of this plant on all 29 bacteria including MDR phenotypes (with MIC values ranging between 256 and 1024 μg/mL).

Role of efflux pumps in the susceptibility of Gram-negative bacteria to the tested extracts and effects of the association of some extracts with antibiotics
------------------------------------------------------------------------------------------------------------------------------------------------------------

All the bacterial strains tested with a combination of plant extract and PAβN were proven to possess multidrug resistance efflux pumps \[[@B55]-[@B59]\]. Tripartite efflux systems, mainly those clinically described such as AcrAB-TolC in Enterobacteriaceae or MexAB-OprM in *P. aeruginosa* play a central role in multidrug resistance of pathogenic Gram-negative bacteria \[[@B55],[@B56]\]. PAßN, a potent inhibitor of the RND efflux systems is especially active on AcrAB-TolC and MexAB-OprM \[[@B57],[@B58]\] and does not present any intrinsic effect on the bacteria at the concentration of 30 μg/mL used in this work \[[@B59]\]. In the presence of PAßN at this concentration, significant increase of the activity of the extract from *P. nigrum* was noted against 13/14 of the tested MDR bacteria. This shows that at least one active compound from this plant, acting inside the bacteria cell could be the substrate of efflux pumps. From this observation, it can be suggested that the association of the extract of *P. nigrum* and efflux pump inhibitors could be helpful in the fight against infections due to MDR bacteria \[[@B5]\].

Moreover, we demonstrated in this study that the beneficial effect of the combination of two of the tested plant extracts namely those from *P. nigrum* and *T. occidentalis,* with the first line antibiotics could be achieved. Their synergistic effects with antibiotics were noted on more than 70% of the tested MDR bacteria (with seven antibiotics), also suggesting that some of their constituents can act as efflux pump inhibitor \[[@B49]\]. This hypothesis is emphasized by the fact that these extracts were more synergistic with antibiotics acting inside the bacteria cells. Besides, it has already been proved that the extract from *P. nigrum* can also act by improving the penetration of antibiotics in cells *via* membrane alteration \[[@B54]\]. However, further phytochemical investigations will be done to isolate the active constituents of *P. nigrum*, *T. occidentalis* and *V. amygdalina*. Besides, toxicological studies will be carried out to evaluate their safety.

Conclusion
==========

The overall results of the present study provide baseline information for the possible use of the tested plants and mostly *P. nigrum, T. occidentalis and V. amygdalina* in the control of infections due to MDR Gram-negative bacteria. In addition, the extracts from *P. nigrum* and *T. occidentalis* could be used in association with antibiotics to combat multidrug resistant pathogens.
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